{"id":93,"date":"2025-08-01T23:18:06","date_gmt":"2025-08-01T23:18:06","guid":{"rendered":"https:\/\/resilientclarity.org\/?p=93"},"modified":"2025-08-01T23:18:06","modified_gmt":"2025-08-01T23:18:06","slug":"comparing-rates-of-anxiety-and-related-side-effects-across-adhd-medication-classes","status":"publish","type":"post","link":"https:\/\/resilientclarity.org\/?p=93","title":{"rendered":"Comparing Rates of Anxiety and Related Side Effects Across ADHD Medication Classes"},"content":{"rendered":"\n<p>ADHD Medications:<\/p>\n\n\n\n<p>How Often Do They Cause Anxiety or Similar Symptoms?<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>ADHD medications are effective, but anxiety, nervousness, and restlessness are common side effects. <\/p>\n\n\n\n<p>Here\u2019s a quick overview of how often these symptoms are reported with each major medication class.<\/p>\n\n\n\n<p>Stimulants(Methylphenidate: <\/p>\n\n\n\n<p>Ritalin, Concerta; Amphetamines: Adderall, Vyvanse)<\/p>\n\n\n\n<p>Anxiety or nervousness: 2% to 15% of patients<\/p>\n\n\n\n<p>Restlessness or insomnia: 10% to 25% of patients<\/p>\n\n\n\n<p>Amphetamines (like Adderall) may have slightly higher rates than methylphenidate (like Ritalin).<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Atomoxetine (Strattera)<\/p>\n\n\n\n<p>Anxiety: 6% to 10% of patients<\/p>\n\n\n\n<p>Insomnia: 5% to 10% of patients<\/p>\n\n\n\n<p>Sometimes preferred for patients with both ADHD and anxiety.<\/p>\n\n\n\n<p>Alpha-2 Agonists(Guanfacine ER\/Intuniv, Clonidine ER\/Kapvay)<\/p>\n\n\n\n<p>Anxiety: Rare (less than 2%)<\/p>\n\n\n\n<p>Drowsiness or sedation is much more common than anxiety.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Bupropion (Wellbutrin, off-label for ADHD)<\/p>\n\n\n\n<p>Anxiety or agitation: 2% to 7% of patients<\/p>\n\n\n\n<p>Insomnia: 10% to 15% of patients<\/p>\n\n\n\n<p>Can help with depression, but may cause anxiety in some.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Key Points<\/p>\n\n\n\n<p>Stimulants are most likely to cause anxiety and restlessness, especially at higher doses.Atomoxetine is a non-stimulant option that may be better for patients with anxiety, but can still cause symptoms. Alpha-2 agonists rarely cause anxiety and may help with sleep, but sedation is common. Bupropion can be helpful for ADHD with depression, but may increase anxiety in some.<\/p>\n\n\n\n<p>Summary:<br>When choosing ADHD medications, consider the patient\u2019s history of anxiety and monitor for these side effects. Adjusting the medication or dose can often help minimize anxiety and improve outcomes.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>For more information, contact Dr. Justin L Herbert, PharmD\/RPh, Integrative Pharmacy Specialist, Charlotte, NC.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ADHD Medications: How Often Do They Cause Anxiety or Similar Symptoms? ADHD medications are effective, but anxiety, nervousness, and restlessness are common side effects. Here\u2019s a quick overview of how often these symptoms are reported with each major medication class. Stimulants(Methylphenidate: Ritalin, Concerta; Amphetamines: Adderall, Vyvanse) Anxiety or nervousness: 2% to 15% of patients Restlessness [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[57,48,44],"tags":[41,50,61,13,46,42,43,62],"class_list":["post-93","post","type-post","status-publish","format-standard","hentry","category-adhd","category-mental-health-wellness","category-neurodivergent","tag-adhd","tag-depression","tag-medications","tag-mind-body-connection","tag-motivation","tag-nd","tag-neurodivergent","tag-pharmaceuticals"],"_links":{"self":[{"href":"https:\/\/resilientclarity.org\/index.php?rest_route=\/wp\/v2\/posts\/93","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/resilientclarity.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/resilientclarity.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/resilientclarity.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/resilientclarity.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=93"}],"version-history":[{"count":1,"href":"https:\/\/resilientclarity.org\/index.php?rest_route=\/wp\/v2\/posts\/93\/revisions"}],"predecessor-version":[{"id":94,"href":"https:\/\/resilientclarity.org\/index.php?rest_route=\/wp\/v2\/posts\/93\/revisions\/94"}],"wp:attachment":[{"href":"https:\/\/resilientclarity.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=93"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/resilientclarity.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=93"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/resilientclarity.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=93"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}